Ríhová B - Search Results

1

Polymeric drugs based on conjugates of synthetic and natural macromolecules. I. Synthesis and physico-chemical characterisation.

Ulbrich K, Subr V, Strohalm J, Plocová D, Jelínková M, Ríhová B. Ulbrich K, et al. Among authors: rihova b. J Control Release. 2000 Feb 14;64(1-3):63-79. doi: 10.1016/s0168-3659(99)00141-8. J Control Release. 2000. PMID: 10640646

2

Star structure of antibody-targeted HPMA copolymer-bound doxorubicin: a novel type of polymeric conjugate for targeted drug delivery with potent antitumor effect.

Kovár M, Strohalm J, Etrych T, Ulbrich K, Ríhová B. Kovár M, et al. Among authors: rihova b. Bioconjug Chem. 2002 Mar-Apr;13(2):206-15. doi: 10.1021/bc010063m. Bioconjug Chem. 2002. PMID: 11906257

3

HPMA-hydrogels containing cytostatic drugs. Kinetics of the drug release and in vivo efficacy.

St'astný M, Plocová D, Etrych T, Kovár M, Ulbrich K, Ríhová B. St'astný M, et al. Among authors: rihova b. J Control Release. 2002 May 17;81(1-2):101-11. doi: 10.1016/s0168-3659(02)00047-0. J Control Release. 2002. PMID: 11992683

4

Cytostatic and immunomobilizing activities of polymer-bound drugs: experimental and first clinical data.

Ríhová B, Strohalm J, Prausová J, Kubácková K, Jelínková M, Rozprimová L, Sírová M, Plocová D, Etrych T, Subr V, Mrkvan T, Kovár M, Ulbrich K. Ríhová B, et al. J Control Release. 2003 Aug 28;91(1-2):1-16. doi: 10.1016/s0168-3659(03)00235-9. J Control Release. 2003. PMID: 12932633

5

Starlike vs. classic macromolecular prodrugs: two different antibody-targeted HPMA copolymers of doxorubicin studied in vitro and in vivo as potential anticancer drugs.

Jelínková M, Strohalm J, Etrych T, Ulbrich K, Ríhová B. Jelínková M, et al. Among authors: rihova b. Pharm Res. 2003 Oct;20(10):1558-64. doi: 10.1023/a:1026170830782. Pharm Res. 2003. PMID: 14620507

6

Chemotherapy based on HPMA copolymer conjugates with pH-controlled release of doxorubicin triggers anti-tumor immunity.

Mrkvan T, Sirova M, Etrych T, Chytil P, Strohalm J, Plocova D, Ulbrich K, Rihova B. Mrkvan T, et al. Among authors: rihova b. J Control Release. 2005 Dec 10;110(1):119-29. doi: 10.1016/j.jconrel.2005.09.028. Epub 2005 Nov 2. J Control Release. 2005. PMID: 16269198

7

Properties of HPMA copolymer-doxorubicin conjugates with pH-controlled activation: effect of polymer chain modification.

Chytil P, Etrych T, Konák C, Sírová M, Mrkvan T, Ríhová B, Ulbrich K. Chytil P, et al. Among authors: rihova b. J Control Release. 2006 Sep 28;115(1):26-36. doi: 10.1016/j.jconrel.2006.06.028. Epub 2006 Jun 30. J Control Release. 2006. PMID: 16899320

8

Star-shaped immunoglobulin-containing HPMA-based conjugates with doxorubicin for cancer therapy.

Etrych T, Mrkvan T, Ríhová B, Ulbrich K. Etrych T, et al. Among authors: rihova b. J Control Release. 2007 Sep 11;122(1):31-8. doi: 10.1016/j.jconrel.2007.06.007. Epub 2007 Jun 16. J Control Release. 2007. PMID: 17631976

9

Conjugates of doxorubicin with graft HPMA copolymers for passive tumor targeting.

Etrych T, Chytil P, Mrkvan T, Sírová M, Ríhová B, Ulbrich K. Etrych T, et al. Among authors: rihova b. J Control Release. 2008 Dec 18;132(3):184-92. doi: 10.1016/j.jconrel.2008.04.017. Epub 2008 Apr 29. J Control Release. 2008. PMID: 18534705

10

HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity.

Etrych T, Strohalm J, Kovár L, Kabesová M, Ríhová B, Ulbrich K. Etrych T, et al. Among authors: rihova b. J Control Release. 2009 Nov 16;140(1):18-26. doi: 10.1016/j.jconrel.2009.07.011. Epub 2009 Jul 24. J Control Release. 2009. PMID: 19632282

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters